XML 74 R58.htm IDEA: XBRL DOCUMENT v3.24.0.1
Restructuring Charges and Other Costs Associated with Acquisitions and Cost-Reduction/Productivity Initiatives - Restructuring Benefits and Charges (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Restructuring Reserve [Roll Forward]      
Beginning balance $ 15 [1] $ 25 $ 21
Provision/(benefit) 46 6 33
Utilization and other [2] (25) (14) (16)
Ending balance 35 [1] 15 [1] 25
Non-cash activity 1 2 13
Other current liabilities      
Restructuring Reserve [Roll Forward]      
Accrued expenses 26 5  
Other non-current liabilities      
Restructuring Reserve [Roll Forward]      
Other noncurrent liabilities 9 10  
Employee Severance      
Restructuring Reserve [Roll Forward]      
Beginning balance 14 [1] 23 21
Provision/(benefit) [3],[4] 41 3 17
Utilization and other [2] (23) (12) (15)
Ending balance 32 [1] 14 [1] 23
Non-cash activity 0 0  
Exit Costs      
Restructuring Reserve [Roll Forward]      
Beginning balance 1 [1] 2 0
Provision/(benefit) 4 1 3
Utilization and other [2] (2) (2) (1)
Ending balance 3 [1] 1 [1] 2
Non-cash activity 0 0 0
Facility Closing      
Restructuring Reserve [Roll Forward]      
Provision/(benefit) 1 2  
Non-cash activity 1 $ 2 $ 13
Employee Severance and Exit Costs      
Restructuring Reserve [Roll Forward]      
Contractual obligation 26    
Payments expected in 2022 25    
Payments expected thereafter $ 1    
[1] At December 31, 2023 and 2022, included in Accrued Expenses ($26 million and $5 million, respectively) and Other noncurrent liabilities ($9 million and $10 million, respectively).
[2] Includes adjustments for foreign currency translation.
[3] The restructuring charges are associated with the following:
For the year ended December 31, 2023, Manufacturing/research/corporate of $22 million, U.S. of $3 million and International of $21 million.
For the year ended December 31, 2022, Manufacturing/research/corporate of $2 million and International of $4 million.
For the year ended December 31, 2021, Manufacturing/research/corporate of $21 million and International of $12 million.
[4] The restructuring charges for the year ended December 31, 2023 primarily relates to employee termination and exit costs related to organizational structure refinements and other cost-reduction and productivity initiatives.
    The restructuring charges for the year ended December 31, 2022 primarily relates to employee termination and exit costs associated with cost-reduction and productivity initiatives in certain international markets, as well as asset impairment charges primarily related to the consolidation of manufacturing sites in China.
    The restructuring charges for the year ended December 31, 2021 primarily relates to the realignment of our international operations and other cost-reduction and productivity initiatives.